India’s pharma market, valued around INR 2.17 lakh crore, faces mounting profit pressure as fake drugs erode trust and government Jan Aushadhi initiatives intensify competition. Industry voices point to early signs of fatigue, but many insist the sector isn’t collapsing and a rebound could still be on the horizon if enforcement and demand dynamics improve.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
